US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 253.010
- -0.060-0.02%
Close Dec 2 16:00 ET
- 253.010
- 0.0000.00%
Post 20:01 ET
32.63BMarket Cap-96568P/E (TTM)
255.290High252.000Low510.77KVolume252.370Open253.070Pre Close129.54MTurnover0.40%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High1008.01P/B32.49BFloat Cap141.97552wk Low--Dividend TTM128.43MShs Float304.390Historical High--Div YieldTTM1.30%Amplitude3.650Historical Low253.618Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet